Ads
related to: acute asthma exacerbation management guidelines- Adverse Reactions
Learn About The Adverse Reactions
Of This Daily Asthma Treatment.
- Dosing Information
HCPs: See The Dosing Information Of
This Once-Daily Asthma Inhaler.
- Samples & Savings
Request Samples For Your Practice
Daily Triple Therapy Asthma Option.
- Triple Therapy Delivery
View The Delivery Methods Of This
Daily Triple Therapy Asthma Option.
- Important Safety Info
Read About Safety & Side Effects
For An Asthma Triple Therapy.
- Resources & Information
Access Resources & Important Info
For An Asthma Therapy Here.
- Adverse Reactions
Search results
Results From The WOW.Com Content Network
Acute severe asthma. Silent chest, worsening symptoms despite use of medication. [1] Acute severe asthma, also known as status asthmaticus, is an acute exacerbation of asthma that does not respond to standard treatments of bronchodilators (inhalers) and corticosteroids. [2] Asthma is caused by multiple genes, some having protective effect, with ...
Acute severe asthma, previously known as status asthmaticus, is an acute exacerbation of asthma that does not respond to standard treatments of bronchodilators and corticosteroids. [115] Half of cases are due to infections with others caused by allergen, air pollution, or insufficient or inappropriate medication use. [115]
An anti-asthmatic agent, also known as an anti-asthma drug, refers to a drug that can aid in airway smooth muscle dilation to allow normal breathing during an asthma attack or reduce inflammation on the airway to decrease airway resistance for asthmatic patients, or both. The goal of asthmatic agents is to reduce asthma exacerbation frequencies ...
Specialty. Pulmonology. Asthma is a common pulmonary condition defined by chronic inflammation of respiratory tubes, tightening of respiratory smooth muscle, and episodes of bronchoconstriction. [1] The Centers for Disease Control and Prevention estimate that 1 in 11 children and 1 in 12 adults have asthma in the United States of America. [1]
1–15% of cystic fibrosis patients and 2.5% of adults with severe asthma. [3] Allergic bronchopulmonary aspergillosis (ABPA) is a condition characterised by an exaggerated response of the immune system (a hypersensitivity response) to the fungus Aspergillus (most commonly Aspergillus fumigatus). It occurs most often in people with asthma or ...
Global Initiative for Asthma. The Global Initiative for Asthma (GINA) is a medical guidelines organisation which works with public health officials and health care professionals globally to reduce asthma prevalence, morbidity, and mortality. GINA was launched in 1993 as a collaboration between National Heart, Lung, and Blood Institute, National ...
Ads
related to: acute asthma exacerbation management guidelines